Lymphatic Forum
in Chicago, IL
June 8-10, 20
17
Vasculata 2017
Chicago, IL
July 24-27, 2017
(new dates!)
October 15-19, 2017
20th IVBM
Helsinki, Finland
June 3-7, 2018
|
Diamond Level
Welcome Reception Host
|
|
|
In 2018, we will continue to incorporate "member developed" sessions for Vascular Biology, NAVBO's annual meeting. We are seeking submissions in any area of research that members consider topical as well as ideas for the Vascular Therapeutics session. The featured workshops at Vascular Biology 2018 will be Biology of Signaling in the Cardiovascular System and Vascular Inflammation. Please note the deadline will be earlier this year - April 3, 2017.
See the web site for more details.
|
EMBO Science Solidarity List
The European Molecular Biology Organisation (EMBO) has set up The Science Solidarity List, a list of scientists offering temporary bench or desk space, library access and possibly even accommodations for US-based scientists who are stranded abroad due to the White House Executive Order 13769 "Protecting the Nation from Foreign Terrorist Entry into the United States" as of January 27, 2017.
If you know a US-based scientist affected by this ban, please direct them to this list of scientists who may be able to offer some assistance. If you run a lab outside of the United States and are able to provide some kind of support, please add your name to the list.
New Newsletter for Scientists from Cure HHT
Stay current on HHT science with the new Cure HHT newsletter designed specifically for researchers and doctors interested in Hereditary Hemorrhagic Telangiectasia. Subscribe to "HHT Frontlines: Bringing Science from Bench to Bedside" by emailing
[email protected] with your:
- Name, credentials (MD, PhD)
- Institution
- City, State, Country
- Are you a Researcher or Physician
- Email address
Vascular Surgery Visiting Professional Program for International Clinicians
The Guy's and St Thomas' NHS Foundation Trust Vascular Surgery Visiting Professionals Programme (VPP) is designed to provide international visiting professionals with the opportunity to profit from exposure to cutting edge endovascular case selection, planning, operative technique and new developments in the field. The program's aim is to provide a unique development experience intended to broaden a visiting professional's surgical education and to teach new skills with which the participant can ultimately enhance his/her home institution. The program offers an unrivaled opportunity covering the full range of vascular and endovascular surgery in a high volume, world class vascular unit in the heart of London.
The remit of the Endovascular VPP is to offer focused training in complex endovascular endografting of the full range of aortic pathologies that affect the aorta from the aortic valve to the femoral vessels. In addition, the unit maintains a comprehensive complex open aortic service and VPP participants are encouraged to profit from the learning opportunities that are available in open aortic surgery.
|
|
Spotlight on Trainees
(from February 2 issue)
|
The power and pitfalls of public speaking
Andrew Gaudet and Laura Fonken, postdocs at the University of Colorado, Boulder, have produced a
helpful set of tips
to improve the effectiveness of oral presentations. Some of their pieces of advice ("Use your laser pointer effectively") may be traceable to the primordial seminar ("Make sure all the family can see the ground where you are drawing with your stick"), while others are unmistakably modern ("
Use the 'Slide Sorter' PowerPoint view to understand the big picture"). All, however, are valuable and well worth remembering-by first-time and experienced speakers alike.
|
Welcome to our New Members:
Suhnrita Chaudhuri, University of Illinois at Chicago
Victoria Mastej, University of Illinois at Chicago
Matthew Woolard, Louisiana State University HSC - Shreveport
|
|
Recent Publications by NAVBO Members
|
| Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease
American Journal of Physiology - Heart and Circulatory Physiology
In Alzheimer's disease (AD), cerebral arteries, in contrast to cerebral microvessels, show both cerebral amyloid angiopathy- (CAA) dependent and -independent vessel wall pathology. However, it remains unclear whether CAA-independent vessel wall pathology affects arterial function thereby chronically reducing cerebral perfusion, and if so which mechanisms mediate this effect. Read more
|
|
Industry News
(from February 2 issue)
|
The NIH Common Fund Rallies Behind "The Vasculome"
Zorina Galis, PhD, Vascular Biology & Hypertension Branch Chief in the
Division of Cardiovascular Sciences at the NHLBI and an organizer of the "Vasculome" session at IVBM 2016, reports that the
NIH Common Fund
has approved the
Human BioMolecular Atlas Platform
(HuBMAP) for funding in FY2018. Common Fund programs support cross-cutting, trans-NIH programs that require participation by at least two NIH Institutes or Centers or would otherwise benefit from strategic planning and coordination. Specific Funding Opportunity Announcements for HuBMAP, currently under development and inspired in part by the Vasculome proposal, will aim to facilitate research on single cells within human tissues by building a central platform that would bring together data from around the world and make it accessible to the entire scientific community. Learn more about Common Fund initiatives here.
Propranolol approved for angiosarcoma in Europe
The beta-adrenergic antagonist propranolol, frequently prescribed as an antihypertensive, was recently granted Orphan Drug Designation by the European Commission to
treat soft tissue sarcoma
. The cancer affects approximately one quarter of a million people living in Europe, and, according to investigator Brad Bryan, Ph.D., at Texas Tech University, affected patients "...have a very poor survival rate. Four out of 10 patients with the cancer will die and are in urgent need of new treatment options." Dr. Bryan's lab reported the efficacy of propranolol in
attenuation of cutaneous angiosarcoma
.
Whose dime accounts for the lion's share of medical advances?
Thomas Stossel, MD, Professor Emeritus at Harvard Medical School and visiting scholar at the American Enterprise Institute, writes in
The Wall Street Journal
(January 6, 2017) that medical innovations arise principally from work in the private sector rather than through federally-funded academic institutions. His article, "Don't Thank Big Government for Medical Breakthroughs," describes the merit of closer interaction between academia and industry, favoring more directed, goal-oriented research of the basic variety. Stossel expands on these views in
National Affairs
, tempered by the acknowledgement of a need for federal "subsidy" of university basic research and training, although to a more limited extent than currently practiced.
|
|
Job Postings
|
|
Job Title
|
Company
|
Location
|
|
|
University of North Carolina
|
Chapel Hill, NC
|
Associate/Full Professor
|
University of Toronto
|
Toronto, Ontario
|
|
|
Stanford School of Medicine
|
Stanford, CA
|
Post Doctoral Fellow
|
Medical College of Wisconsin
|
Milwaukee, WI
|
|
|
University of California, San Francisco
|
San Francisco, CA
|
Assistant Professor
|
University of Toronto
|
Toronto, Ontario
|
|
|
Gold Level
Academic Supporter
 |
|
Silver Level Academic Supporters
|
|
|
|
Bronze Level Academic Supporters
|
|
|
